Organic Health Adviser has been most instrumental in collecting personal stories of miscarriages and stillbirths of women who were convinced to take the H1N1 vaccine. Read the personal stories…
Organic Health Advisers covers many cutting edge issues like GMO foods, Aspartame, healthy choices…the whole range…
It also has organic product recommendations from diapers to essential oils; from organic mattresses to organic dog food
PROVE provides information on vaccines, and the immunization policies and practices that affect the children and adults of Texas. PROVE mission is to prevent vaccine injury and death and to promote and protect the right of every person to make informed independent vaccination decisions for themselves and their families. DAWN RICHARDSON, founder of PROVE has successfully passed positive legislation in Texas as it pertains to vaccines. She is also associated with the National Vaccine Information Center NVIC
“Oreo” died from Vaccine Associated Feline Sarcoma (VAFS). Read more on vaccines…
Wednesday, August 25, 2010
Although the national count for Whooping Cough is circa 100 persons and no cases in California, Mainstream media health professionals shills report false facts that California has circa 800 cases and 6 infant deaths in order to frighten the population into get vaccinated. As well, they accuse non-vaccinated children of harming the communities and are beginning to challenge the State vaccine exemption laws.
Is aerial spraying tied to whooping cough in California? Read…
Reports on cutting news happenings on health-body, mind and spirit, while stealthily exposing the divisive strategies of the corporate elite, government and media; that is those entities and agencies who promote false notions on health and disease. Prevent Disease site… Go to site…
Morgellons: Emerging Nanotechnology is Threatening All Living Things
The emerging disease called Morgellons is caused by nano “machines” which are believed to receive specific microwave, EMF and ELF signals and information.There is strong evidence linking Chemtrail aerosol fibers to Morgellons fibers. There are more than 10,000 families who report that they suffer from this disease, Morgellons nano machines are commonly found in all body fluids and orifices, and are believed to routinely achieve total body systemic penetration. Symptoms Go to Morgellons Exposed Website for photos and stories
After 13 years of suffering with Lyme disease (related to Morgellons Disease), a possible cure has been stumbled upon. A cumulative effect of much research has produced the possibility that salt and vitamin C may be all that is needed to beat this elusive illness. Without going into a lot of detail, our theory is that Lyme is not just a bacterial disease, but also an infestation of microfilarial worms. Bacteria, worms, internal mites and the possibility of other creatures have been quite horrifying.Salt cure
Morgellons patents: US 6245531 Polynucleotides Encoding Insect Ecdysone Receptor http://www.patentlens.net/imageserver... US 5514578A Polynucleotides Encoding Insect Steroid Hormone Receptor Polypeptides and Cells Transformed With Same http://www.patentlens.net/patentlens/... Inventors: David Hogness, 650-723-6166, tran@cmgm.stanford.edu Michael Koelle, 203-432-5662, Michael.koelle@yale.edu William Seagraves, 203-432-4537, William.seagraves@yale.edu —————————————-—————————————- SPRING HOUSE, Pa.–(BW HealthWire)–May 7, 2002 Agreement grants Invitrogen nonexclusive, worldwide rights to manufacture and sell Ecdysone-Inducible Expression research kits RHeoGene today announced it has egotiated an agreement to grant Invitrogen (Carlsbad, CA) a nonexclusive, worldwide sublicense for sales of Invitrogen’s Ecdysone-Inducible Expression System and related products for research purposes only. RHeoGene holds an exclusive license to Stanford University patents U.S. 5,514,578, 6,245,531 and EP Patent 0517805 that cover sales and use of certain ecdysone-based products. Invitrogen has been manufacturing and selling its Ecdysone- Inducible Expression System under a separate license since 1996. Under its license from RHeoGene, Invitrogen will continue to provide Ecdysone-Inducible Expression System products to academic, government, industrial, and clinical institutions for research purposes. Customers wishing to use ecdysone receptor-based gene expression systems for commercial purposes should contact RHeoGene for a commercial license. “This licensing agreement is the first external validation of the importance of RHeoGene’s exclusive license to the intellectual property encompassed by these Stanford patents after broader claims to U.S. 5,514,578 were granted,” said Tom Tillett, RHeoGene Executive Vice President for Operations. The Stanford patents are directed to genes that encode insect-based ecdysone receptors from a broad range of insect species and methods for regulating gene expression in host cells. The patent coverage includes ecdysone receptor (EcR) genes originating from Drosophila, the basis of Invitrogen’s Ecdysone-Inducible Expression System. The patents are based on the pioneering research of Dr. David Hogness, Emeritus Munzer Professor of Developmental Biology and Biochemistry at Stanford University. RHeoGene’s exclusive license to these patents encompasses all uses outside of plants, including cell-based assays, genomics, proteomics, gene therapy, cell culture/fermentation, transgenic animals, and biosensors. RHeoGene focuses on delivering customized inducible gene expression technology systems to advance proteomics, drug discovery, biotherapeutics production, and human gene therapy. RHeoGene’s operations are located in Spring House, Pa., and Charlottesville, Va. For more information, visit www.rheogene.com.
